Pfizer’s chief strategy and innovation officer Andrew Baum is stepping down merely two years into the role, according to reports.
Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula
Pfizer’s chief strategy and innovation officer Andrew Baum is stepping down merely two years into the role, according to reports.